Canaccord Genuity Reiterates a 'Buy' on Heartware Int'l (HTWR); ADVANCE BTT Data Published
Tweet
Share
E-mailGet Alerts HTWR Hot Sheet
Price: $57.98 --0%
Rating Summary:
5 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
5 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Heartware Int'l (NASDAQ: HTWR) price target of $101.00.
Analyst, Jason R. Mills, said, "Data from HTWR’s ADVANCE BTT was published in Circulation, which is arguably more prestigious than JACC, on-line yesterday. The publication opens the door for further analyses that include the CAP cohorts, which we believe will be integral to HVAD marketing. We continue to model for FDA approval in September."
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $78.57 yesterday.
Analyst, Jason R. Mills, said, "Data from HTWR’s ADVANCE BTT was published in Circulation, which is arguably more prestigious than JACC, on-line yesterday. The publication opens the door for further analyses that include the CAP cohorts, which we believe will be integral to HVAD marketing. We continue to model for FDA approval in September."
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $78.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
